Skip to Content Facebook Feature Image

Medicinal Genomics’ One-Reaction Listeria Test Earns AOAC Certification for Whey Powder, Foods, and Surfaces

Business

Medicinal Genomics’ One-Reaction Listeria Test Earns AOAC Certification for Whey Powder, Foods, and Surfaces
Business

Business

Medicinal Genomics’ One-Reaction Listeria Test Earns AOAC Certification for Whey Powder, Foods, and Surfaces

2026-11-19 23:10 Last Updated At:23:20

BEVERLY, Mass.--(BUSINESS WIRE)--Nov 19, 2026--

Medicinal Genomics Corporation (MGC) today announced that its PathoSEEK® Listeria mono & spp. Multiplex Detection Assay with MaGiC™ Lysis has earned AOAC Research Institute's Performance Tested Methods ℠ certification (No. 112601) for whey powder, ready-to-eat meats, fresh spinach, and environmental surfaces. The qPCR test detects Listeria species and Listeria monocytogenes in a single reaction, delivers next-day results for most sample types, and is designed for automation on Bio Molecular Systems’ Myra liquid handler.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119725123/en/

Highlights from the PTM Certification Study at Q Laboratories

Listeria Contamination Risk
Listeria has the highest fatality rate of the major foodborne pathogens. The CDC estimates it sickens about 1,600 Americans a year and kills about 260, and nearly everyone diagnosed is hospitalized. In 2025, Listeria caused 21 of the 22 deaths in U.S. foodborne illness outbreaks, according to U.S. PIRG’s Food for Thought 2026 report. Recent outbreaks tied to nutritional shakes (14 deaths), deli meat (10), and prepared pasta meals (7) killed 31 people. In the pasta outbreak, almost a year passed between the first illness and the recall.

“ Listeria caused nearly every U.S. foodborne outbreak death last year, and the outbreaks keep showing the same pattern: contamination found weeks or months too late,” said Brendan McKernan, CEO of Medicinal Genomics. “Nutritional shakes are part of that story. Certifying whey powder alongside meats, produce, and environmental surfaces adds Listeria to our microbial testing solution for supplements.”

Food manufacturers swab surfaces for Listeria species as an early warning and test product for L. monocytogenes itself. Many qPCR methods use a separate kit for each target. One reaction answers both questions with one sample and one run. An internal control in every reaction guards against false negatives. An optional certified step removes DNA from dead cells, which can skew qPCR results after sanitation.

Certified by Independent Reviewers
AOAC PTM certification is an independent review confirming that a test performs as its maker claims. Q Laboratories, an independent food microbiology laboratory, ran the inclusivity, exclusivity, and matrix studies. It compared the assay with USDA MLG 8.15 and FDA BAM Chapter 10. On stainless steel and ceramic, paired testing showed results equivalent to the reference method.

“Rapid methods offer significant advantages by reducing turnaround times, enabling quicker decision-making, and helping food manufacturers identify potential microbiological hazards before products reach consumers. However, speed alone is not enough,” said Ben Bastin, Director of Microbiology Operations at Q Laboratories. “These methods must be thoroughly validated to demonstrate that they are accurate, reliable, reproducible, and fit for their intended purpose. Robust validation provides confidence that rapid methods perform consistently across different food matrices, processing environments, and testing conditions. The PathoSEEK Listeria method has been validated for select foods and environmental surfaces and compared to the U.S. reference methods. By statistically comparing the rapid method and the reference method, no statistical differences were observed.”

Designed with Automation in Mind
The PathoSEEK workflow is easily automated using the Bio Molecular Systems (BMS) Myra liquid handler, which prepares 46 samples in under 15 minutes, limiting hands-on time and user error. Medicinal Genomics recommends the BMS Mic qPCR cycler, which produces results in under two hours; the assay is also certified on Bio-Rad CFX96 Touch and CFX Opus systems. The kit (catalog no. 420545) is available now. Food and supplement labs can find the full validation data package at medicinalgenomics.com/product-literature.

Mic and Myra are trademarks of Bio Molecular Systems Pty Ltd. Bio-Rad, CFX96 Touch, and CFX Opus are trademarks of Bio-Rad Laboratories, Inc. All other trademarks are the property of their respective owners.

About Medicinal Genomics
Medicinal Genomics is a molecular diagnostics company that develops PathoSEEK® qPCR assays and automated workflows for microbial testing in regulated industries. Having built its platform in cannabis and hemp testing, the company now serves dietary supplements, natural products, and food manufacturers. Its patent-pending LIDAR qPCR reporter chemistry combines quantification, deep multiplexing, and high-resolution melt in one reaction on existing thermocyclers. Learn more at medicinalgenomics.com.

Follow Medicinal Genomics on LinkedIn, X, Instagram, Facebook and YouTube.

Medicinal Genomics’ AOAC-certified Listeria testing workflow: the Bio Molecular Systems Myra liquid handler for automated sample prep, the Mic qPCR cycler, and the PathoSEEK® Listeria mono & spp. Multiplex Detection Assay (AOAC PTM No. 112601). The assay detects Listeria species and Listeria monocytogenes in a single reaction and is certified for whey powder, ready-to-eat meats, fresh spinach, and environmental surfaces.

Medicinal Genomics’ AOAC-certified Listeria testing workflow: the Bio Molecular Systems Myra liquid handler for automated sample prep, the Mic qPCR cycler, and the PathoSEEK® Listeria mono & spp. Multiplex Detection Assay (AOAC PTM No. 112601). The assay detects Listeria species and Listeria monocytogenes in a single reaction and is certified for whey powder, ready-to-eat meats, fresh spinach, and environmental surfaces.

NEW YORK (AP) — Walmart reported solid third-quarter sales gains as the retailer continues to attract a growing number of customers across the economic spectrum that are seeking to cut costs in the face of rising prices.

The company topped Wall Street’s profit and sales projections, and it raised its annual guidance for the third time this year, but the outlook released Thursday was more conservative than industry analysts had expected.

Shares fell about 1.5% in morning trading.

Comparable sales, which include digital channels and stores, rose 2.9%. That is better than last quarter's 2.6% increase, when Walmart reported its weakest comparable sales growth in six years. But it's still a slowdown from the 4.5% growth registered during the same period last year.

Still, slowing comparable sales, particularly in Walmart stores, also reflect a strategic shift toward e-commerce, Walmart+ memberships and advertising. Global e-commerce sales rose 17%, while U.S. e-commerce sales increased 23% during the latest quarter, the company said. And the company's advertising business was up 37%, the retailer said.

Walmart said that more than 80% of U.S. e-commerce orders are being fulfilled from stores, including its third-party marketplace orders. Stores enabled faster delivery speeds on a wide range of assortments, the retailer said.

Walmart's CEO John Furner told analysts during a call following the earnings release that e-commerce was the “primary driver again this quarter.”

“We continued to gain market share, units and transactions were strong, and looking ahead, we expect a strong holiday season,” he added.

Walmart is considered a barometer of consumer spending given its vast customer base. More than 150 million customers use its website or visit its stores every week, according to Walmart. Analysts look to the massive retailer for clues about what to expect from the industry as a whole during the critical holiday shopping season.

Consumers in the U.S. have remained resilient in the face of painful inflation, but they have also grown more selective about what they buy. Many rely on retailers like Walmart as a one-stop shop for low-priced household goods, groceries and pharmaceuticals.

The latest U.S. retail sales data revealed that shoppers increased spending more slowly in October as Americans pulled back on a variety of purchases, from cars and clothing to furniture and even their own hobbies.

Retail sales rose 0.2% in October, down from a 0.8% gain in September, according to Commerce Department data released this week.

Walmart has been hammering its low price message while refining its store-label fashion brands like Scoop and Free Assembly.

Walmart is also trying to increase subscriptions to its shipping programs. During the third quarter, Walmart launched a combined Walmart+ and Sam’s Club Plus annual membership bundle for $120 per year. The package saves shoppers nearly $100 compared to buying both plans separately, it said.

Walmart, based in Bentonville, Arkansas, has begun to capture a larger share of wealthier consumers. The biggest gains in market share for Walmart have been coming from households with annual incomes over $100,000, the retailer has said.

Walmart’s quarterly net income was $4.94 billion, or 62 cents per share, in the three-month period ended Oct. 31. Adjusted per-share results were 65 cents, higher than the 64 cents Wall Street had expected, according to FactSet. In the year-ago quarter, the company earned $6.14 billion, or 77 cents per share.

Sales rose 5.2% to $188.8 billion in the latest quarter. Analysts were predicting $187.38 billion, according to FactSet.

The company said that comparable sales were driven by groceries and general merchandise categories like furniture and toys. Walmart said that its grocery business enjoyed the highest market share gains in three years, driven by low prices and faster delivery speeds.

During the fiscal second quarter, Walmart used U.S. tariff refunds to temporarily lower prices on 11,000 items. At the end of the fiscal third period, Walmart had about 7,700 so-called rollbacks, the retailer said.

But the retailer's health and wellness category was once again hit by federal legislation that requires pharmacies to dispense some high-cost Medicare drugs at capped prices, the retailer said. Excluding that category, comparable sales were up 3.6%, Walmart said.

“Walmart continues to capture new customers as well as retaining the ones they secured over the past couple of years,” Neil Saunders, managing director of GlobalData Retail, wrote in a report. “A lot of the switching to Walmart is initially driven by price, which remains the major weapon in Walmart’s armory.”

For the full year, Walmart now projects earnings per share to be in the range of $2.84 to $2.89, up from the prior guidance of $2.80 to $2.87. Sales should be up anywhere from 4.9% to 5.2%, up from the prior forecast of 4% to 5%. That would mean a forecast for sales in the range of $748.12 billion to $750.25 billion, according to FactSet.

Analysts expected $2.89 per share and sales of $752.68 billion for the year, according to FactSet.

FILE - The Walmart logo is displayed on a store, Aug. 14, 2025, in Manchester, N.H. (AP Photo/Charles Krupa, File)

FILE - The Walmart logo is displayed on a store, Aug. 14, 2025, in Manchester, N.H. (AP Photo/Charles Krupa, File)

Recommended Articles